Vivoryon Therapeutics NV banner

Vivoryon Therapeutics NV
AEX:VVY

Watchlist Manager
Vivoryon Therapeutics NV Logo
Vivoryon Therapeutics NV
AEX:VVY
Watchlist
Price: 1.25 EUR 1.63%
Market Cap: €37m

Wall St Price Targets

VVY Price Targets Summary
Vivoryon Therapeutics NV

Wall Street analysts forecast VVY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VVY is 5.95 EUR with a low forecast of 5.05 EUR and a high forecast of 7.88 EUR.

Lowest Forecast
Price Target
5.05 EUR
304% Upside
Average Forecast
Price Target
5.95 EUR
376% Upside
Highest Forecast
Price Target
7.88 EUR
530% Upside
Vivoryon Therapeutics NV Competitors:
Price Targets
INO
Inovio Pharmaceuticals Inc
452% Upside
AYTU
Aytu Biopharma Inc
338% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VVY's stock price target?
Price Target
5.95 EUR

According to Wall Street analysts, the average 1-year price target for VVY is 5.95 EUR with a low forecast of 5.05 EUR and a high forecast of 7.88 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett